Pharminox appoints Iain Ross as Chairman
Pharminox Limited, ("Pharminox" or "the Company") the UK-based cancer drug discovery and development company, today announced that it has appointed Iain Ross as Non-executive Chairman...
read more

_____________________________

ICON Central Laboratories Expands its European Facility to Meet Growing Demand
ICON plc, NASDAQ: ICLR; ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, announced that it has expanded its European Central Laboratory, located in South County Business Park, Dublin...
read more

_____________________________

Dr. Christian Müller to be appointed new CFO of Carl Zeiss Meditec
Dr. Christian Müller (42) is to be appointed as a new member of the Management Board and Chief Financial Officer of Carl Zeiss Meditec AG with effect from 15 December 2009...
read more

_____________________________

Brecon strengthens board line-up
Brecon Pharmaceuticals, the leading supplier of commercial packaging and clinical trials supplies services for the pharmaceutical and healthcare sectors, has announced the appointment of Peter Belden as managing director...
read more

_____________________________

ThromboGenics and BioInvent Win "Licensing Deal of the Year" at the Scrip Awards 2009
ThromboGenics NV (Euronext Brussels: THR) and BioInvent International (OMXS: BINV) announce today that they won "Licensing Deal of the Year" at the Scrip Awards 2009, presented last night...
read more

_____________________________

>>Read more news stories                                                                   

»Stem Cells World Congress
Date: 20 - 21 January 2010
Location: South San Francisco, SA, USA
View Website

________
 
»World Drug Delivery and Formulation 2010
Date: 26 - 27 January 2010
Location: Dusseldorf, Germany
View Website

________
 
»IFPAC 2010
Date: 31 January - 4 February 2010
Location: Baltimore, USA
View Website    

________
     
»Stability Testing of Pharmaceuticals
Date: 22 - 24 February 2010
Location: Cambridge, UK
View Website

Article 6: qPCR data analysis 2 - Controls and Troubleshooting
Tania Nolan, Global Manager of Applications and Technical Support, Sigma-Aldrich, Stephen Bustin, Professor of Molecular Science, Centre for Academic Surgery, Institute of Cell and Molecular Science, Barts and the London School of Medicine and Dentistry

The tremendous increase in the number of laboratories using qPCR and publications relying on qPCR data are testament to the rapid uptake of this technology...

Read article in full

_________________________________

Cellular Imaging & Analysis Business Unit
Mark Collins from Thermo Fisher Scientific, who provide analytical instruments, laboratory equipment, software, services, consumables and reagents, talks to us about current developments and future changes...
Read more

________

________

Basics of image analysis in High Content Screening
Prof Jeremy Simpson, Professor of Cell Biology and Vasanth Singan, PhD student (Bioinformatics and Computational Biomedicine) University College Dublin

Automated high content screening platforms are capable of producing thousands of images per day...

Read article in full

_________________________________

Combining perspectives: Multiscale integration of Stem Cell research
Dr George Plopper, Associate Professor, Rensselaer Polytechnic Institute and Amanda Lund, Postdoctoral Fellow, Integrative Biosciences Institute (IBI) Faculty of Life Sciences

The promise of stem cell-based therapy is predicated on harnessing the plasticity of stem cell phenotypes to repair or replace damaged tissues...

Read article in full
_______________________________

LABORATORY AUTOMATION ROUNDTABLE
Dr Gordon Alton, President and CEO, Altonyx Consulting, Dr Scott Bowes, Scientist, Novartis, Dr Sheraz Gul, Vice President and Head of Biology, European ScreeningPort and Chris Molloy, Vice President of Corporate Development, IDBS

1. What do you feel are the current changing attitudes towards Lab Automation?...

Read article in full
_______________________________ 

The weakest link is getting stronger
Gavin Halbert, Director, Cancer Research UK Formulation Unit, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde

The manufacture of sterile products attracts the greatest regulatory scrutiny of all product types, since manufacturing failures can be fatal and manufacturers are required to utilise the most robust sterilisation method possible to limit the probability of this occurring...

Read article in full

_____________________________